Drug intelligence / Profile preview

Ovaprene

Development stage
Unknown
Lead developer
Daré Bioscience
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravaginal
01

Overview

Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive that combines a physical barrier with the controlled release of non-hormonal agents to prevent pregnancy. The device consists of a flexible silicone ring with a tightly woven polymer matrix across its center. This matrix contains ferrous gluconate (a form of iron), vitamin C, glycine, and polyglycolide microparticles. When inserted into the vagina at the end of menstruation and worn until the next period, Ovaprene acts by two complementary mechanisms: - Physically blocking sperm from entering the cervical canal via its knitted polymer barrier. - Releasing ferrous gluconate and other agents locally to create an environment that impairs sperm motility through lipid peroxidation reactions. Ovaprene is designed for continuous use throughout the menstrual cycle without requiring action at each intercourse or daily administration. It does not contain hormones and does not require clinician fitting. Clinical studies have shown it effectively immobilizes sperm and prevents their progression into cervical mucus[1][2][3][4][5].

Brand names
Ovaprene

Beyond the preview

Go deeper on Ovaprene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovaprene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call